UBS Group’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-375
| Closed | -$45.4K | – | 9027 |
|
|
2023
Q1 | $45.4K | Sell |
375
-42
| -10% | -$5.08K | ﹤0.01% | 5448 |
|
|
2022
Q4 | $47.9K | Sell |
417
-502
| -55% | -$57.6K | ﹤0.01% | 5663 |
|
|
2022
Q3 | $93K | Buy |
919
+426
| +86% | +$43.1K | ﹤0.01% | 4717 |
|
|
2022
Q2 | $50K | Sell |
493
-253
| -34% | -$25.7K | ﹤0.01% | 4908 |
|
|
2022
Q1 | $87K | Buy |
+746
| New | +$87K | ﹤0.01% | 5016 |
|